# E-DRUG: Intellectual Property and Health Care

**URL:** https://talk.edrugplus.org/t/e-drug-intellectual-property-and-health-care/870
**Category:** e-drug
**Created:** [May 29, 1997, 4:44am UTC](https://talk.edrugplus.org/t/e-drug-intellectual-property-and-health-care/870 "1997-05-29T04:44:39Z")
**Posts on this page:** 1
**Page:** 1

<div class="post-metadata">

### Author: ![love](https://avatars.discourse-cdn.com/v4/letter/l/dec6dc/32.png) [@love](https://talk.edrugplus.org/u/love)
#### Post date: [May 29, 1997, 4:44am UTC](https://talk.edrugplus.org/t/e-drug-intellectual-property-and-health-care/870/1 "1997-05-29T04:44:39Z")

</div>

E-drug: Intellectual Property and Health Care  
---------------------------------------------

I recently had the opportunity to participate in discussions over the  
Intellectual Property provisions of the proposed Free Trade Area for the  
Americas (FTAA), in a meeting held in May 1997, in Belo Horizonte, Brazil.  
I will be sending some notes from the discussions to this list at a later  
date. For now I have a URL for the paper I presented at the meetings:  
[http://www.cptech.org/pharm/belopaper.html](http://www.cptech.org/pharm/belopaper.html)

The paper deals with broader issues than health care, but health care is  
the main focus. I spent a fair amount of time talking about compulsory  
licensing, including a number of very recent compulsory licenses in the  
United States (that worldwide opponent of compulsory licensing!), as well  
as some other topics, such as the role of trademarks in protecting  
advertising of infant formula to illiterate mothers, or protections of  
health registration data. The paper was necessarily limited in scope  
(about 9,000 words), but it may be a useful reference for those who are  
learning about intellectual property laws and International trade  
agreements.

&nbsp;&nbsp;&nbsp;&nbsp;Best, James Love \<love@cptech.org\>  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Consumer Project on Technology  
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[http://www.cptech.org](http://www.cptech.org)

---------------------------------------------------------------------  
James Love | Center for Study of Responsive Law | P.O. Box 19367,  
Washington, DC 20036 | love@cptech.org | Voice 202/387-8030 | Fax  
202/234-5176 | Current Projects: Consumer Project on Technology:  
[http://www.cptech.org](http://www.cptech.org) | Antitrust: [http://www.essential.org/antitrust](http://www.essential.org/antitrust)  
---------------------------------------------------------------------

--  
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.  
Mail administrative requests to `majordomo@usa.healthnet.org'.  
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.
